1. Abbrederis K (1977) Klinische Relevanz zytochemischer Befunde bei differenzierten myelogenen Leukämien des Erwachsenen. Wien Klin Wochenschr [Suppl 76] 89
2. Asamer H, Schmalz' F, Braunsteiner H (1971) Immunocytological demonstration of lysozyme (muramidase) in human leukaemic cells. Brit J Haematol 29: 571
3. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Granlnick HR, Sultan C (1976) Proposals for the classification of acute leukaemias. French American British (FAB) Cooperative Group. Br J Haematol 33:451— 458
4. Bernasconi C, Lazzarino M, Morra E (1976) The use of epipodophyllotoxin derivative (VP 16 — 213) in the treatment of acute monocytic and myelomocytic leukemias. In: Stacher A, Höcker P. (Hrsg.) Erkrankungen der Myelopoese. Urban & Schwarzenberg, Miinchen Berlin Wien, 224
5. Bernasconi C, Lazzarino M, Salvaneschi L, Morra E, Canevari A, Castelli G, Ogier C (1979) Acute monocytic and myelomonocytic leukemias. Frequency and therapy. In: Mandelli F (ed) Therapy of acute leukemias. Lombardo, Rome, p 352